
Screening for Anal Dysplasia in HIV-Infected Men Who Have Sex with Men by Anal Cytology, Human Papillomavirus
Testing and Anoscopy
Copyright © 2011 SciRes. WJA
AIDS, Vol. 19, No. 3, 2005, pp. 1407-1414.
doi:10.1097/01.aids.0000181012.62385.4a
[4] J. M. Palefsky, E. A. Holly, M. L. Ralston, S. P. Arthur,
N. Jay, J. M. Berry, M. M. DaCosta, R. Botts and T. M.
Darragh, “Anal Squamous Intraepithelial Lesions in
HIV-Positive and HIV-Negative Homosexual and Bisex-
ual Men: Prevalence and Risk Factors,” Journal of Ac-
quired Immune Deficiency Syndromes & Human Retro-
virology, Vol. 17, No. 4, 1998, pp. 320-326.
doi:10.1097/00042560-199804010-00005
[5] J. M. Palefsky, E. A. Holly, M. L. Ralston, N. Jay, J. M.
Berry and T. M. Darragh, “High Incidence of Anal
High-Grade Squamous Intra-Epithelial Lesions among
HIV-Positive and HIV-Negative Homosexual and Bisex-
ual Men,” AIDS, Vol. 12, No. 5, 1998, pp. 495-503.
doi:10.1097/00002030-199805000-00011
[6] A. de Pokomandy, D. Rouleau, G. Ghattas, H. Trottier, S.
Vezina, P. Cote, J. Macleod, G. Allaire, R. Hadjeres, E. L.
Franco and F. Coutlee, “HAART and Progression to
High-Grade Anal Intraepithelial Neoplasia in Men Who
Have Sex with Men and Are Infected with HIV,” Clinical
Infectious Diseases, Vol. 52, No. 9, 2011, pp. 1174-1181.
doi:10.1093/cid/cir064
[7] I. E. Salit, J. Tinmouth, S. Chong, J. Raboud, C. Diong, D.
Su, M. Sano, A. Lytwyn, W. Chapman and J. Mahony,
“Screening for HIV-Associated Anal Cancer: Correlation
of HPV Genotypes, P16, and E6 Transcripts with Anal
Pathology,” Cancer Epidemiology, Biomarkers & Pre-
vention, Vol. 18, No. 7, 2009, pp. 1986-1992.
doi:10.1158/1055-9965.EPI-08-1141
[8] T. J. Wilkin, S. Palmer, K. F. Brudney, M. A. Chiasson
and T. C. Wright, “Anal Intraepithelial Neoplasia in He-
terosexual and Homosexual HIV-Positive Men with
Access to Antiretroviral Therapy,” Journal of Infectious
Diseases, Vol. 190, No. 9, 2004, pp. 1685-1691.
doi:10.1086/424599
[9] J. R. Daling, M. M. Madeleine, L. G. Johnson, S. M.
Schwartz , K. A. Shera, M. A. Wur scher, J. J. C arter, P. L.
Porter, D. A. Galloway and J. K. McDougall, “Human
Papillomavirus, Smoking, and Sexual Practices in the
Etiology of Anal Cancer,” Cancer, Vol. 101, No. 2, 2004,
pp. 270-280.
[10] J. R. Qualters, N. C. Lee, R. A. Smith and R. E. Aubert,
“Breast and Cervical Cancer Surveillance, United States,
1973-1987,” Morbidity and Mortality Weekly Report
CDC Surveill Summ, Vol. 41, No. 2, 1992, pp. 1-7.
doi:10.1002/cncr.20365
[11] D. Solomon, D. Davey, R. Kurman, A. Moriarty, D. O'-
Connor, M. Prey, S. Raab, M. Sherman, D. Wilbur, T.
Wright Jr. and N. Young, “The 2001 Bethesda System:
Terminology for Reporting Results of Cervical Cytolo-
gy,” Journal of the American Medical Association, Vol.
287, No. 16, 2002, pp. 2114-2119.
doi:10.1001/jama.287.16.2114
[12] J. Monsonego, G. Pollini, M. J. Evrard, P. Sednaoui, L.
Monfort, D. Quinzat, R. Dachez and K. Syrjanen, “Linear
Array Genotyping and Hybrid Capture II Assay in De-
tecting Human Papillomavirus Genotypes in Women Re-
ferred for Colposcopy Due to Abnormal Papanicolaou
Smear,” International Journal of STD & AIDS, Vol. 19,
No. 6, 2008, pp. 385-392.
[13] C. Baleriola, D. Millar, J. Melki, N. Coulston, P. Altman,
N. Rismanto and W. Rawlinson, “Comparison of a Novel
HPV Test with the Hybrid Capture II (hcII) and a Refer-
ence PCR Method Shows High Specificity and Positive
Predictive Value for 13 High-Risk Human Papillomavirus
Infections,” Journal of Clinical Virology, Vol. 42, No. 1,
2008, pp. 22-26. doi:10.1016/j.jcv.2007.12.008
[14] S. L. Huang, A. Chao, S. Hsueh, F. Y. Chao, C. C. Huang,
J. E. Yang, C. Y. Lin, C. C. Yan, H. H. Chou, K. G.
Huang, H. J. Huang, T. I. Wu, M. J. Tseng, J. T. Qiu, C.
T. Lin, T. C. Chang and C. H. Lai, “Comparison between
the Hybrid Capture II Test and an SPF1/GP6+ PCR-
Based Assay for Detection of Human Papillomavirus
DNA in Cervical Swab Samples,” Journal of Clinical
Microbiology, Vol. 44, No. 5, 2006, pp. 1733-1739.
doi:10.1128/JCM.44.5.1733-1739.2006
[15] L. Z. Mo, S. Monnier-Benoit, B. Kantelip, A. Petitjean, D.
Riethmuller, J. L. Pretet and C. Mougin, “Comparison of
AMPLICOR and Hybrid Capture II Assays for High Risk
HPV Detection in Normal and Abnormal Liquid-Based
Cytology: Use of INNO-LiPA Genotyping Assay to
Screen the Discordant Results,” Journal of Clinical Vi-
rology, Vol. 41, No. 2, 2008, pp. 104-110.
doi:10.1016/j.jcv.2007.09.012
[16] S. E. Goldstone, A. Z. Kawalek, R. N. Goldstone and A.
B. Goldstone, “Hybrid Capture II Detection of Oncogenic
Human Papillomavirus: A Useful Tool When Evaluating
Men Who Have Sex with Men with Atypical Squamous
Cells of Undetermined Significance on Anal Cytology,”
Diseases of the Colon & Rectum, Vol. 51, No. 7, 2008, pp.
1130-1136. doi:10.1007/s10350-008-9306-4
[17] K. Holcomb and C. D. Runowicz, “Cervical Cancer
Screening,” Surgical Oncology Clinics of North America,
Vol. 14, No. 14, 2005, pp. 777-797.
doi:10.1016/j.soc.2005.05.011
[18] B. Kleter, L. J. van Doorn, S. J. ter, L. Schrauwen, K. K.
van, M. Burger, H. B. ter and W. Quint, “Novel Short-
Fragment PCR Assay for Highly Sensitive Broad-Spe-
ctrum Detection of Anogenital Human Papillomaviruses,”
American Journal of Pathology, Vol. 153, No. 6, 1998,
pp. 1731-1739. doi:10.1016/S0002-9440(10)65688-X
[19] J. M. Palefsky, E. A. Holly, M. L. Ralston and N. Jay,
“Prevalence and Risk Factors for Human Papillomavirus
Infection of the Anal Canal in Human Immunodeficiency
Virus (HIV)-Positive and HIV-Negative Homosexual
Men,” Journal of Infectious Diseases, Vol. 177, No. 2,
1998, pp. 361-367. doi:10.1086/514194
[20] A. de Pokomandy, D. Rouleau, G. Ghattas, S. Vezina, P.
Cote, J. Macleod, G. Allaire, E. L. Franco and F. Coutlee,
“Prevalence, Clearance, and Incidence of Anal Human
Papillomavirus Infection in HIV-Infected Men: The
HIPVIRG Cohort Study,” Journal of Infectious Diseases,
Vol. 199, No. 7, 2009, pp. 965-973.
doi:10.1086/597207